[ORGANIZATION]
Nurix Therapeutics, Inc.
Featured in 2 tracked stories · first seen
Situations
L3Harris Technologies financial and strategic developments
2 clusters · 2 sources · last updated
Latest: Institutional investors increase stakes in L3Harris and Nurix Therapeutics
L3Harris Technologies reported strong second-quarter 2026 financial results, including $5.9 billion in revenue and a record $42 billion order backlog. Despite these earnings and raised full-year guidance, the company's s
Also covered in
-
Insider Sales Reported at Nurix Therapeutics and Chemring Group
[BUSINESS] · 2 sources ·